Peptonic Medical Clarifies Details on DGH International Share Acquisition
Peptonic Medical AB (publ) has issued a clarification regarding a previous press release concerning its acquisition of a shareholding in DGH International AB. The company corrected information about Mangold Fondkommission AB's role in the transaction.
Peptonic Medical AB (publ) has provided further clarification concerning its acquisition of a shareholding in DGH International AB (formerly Intellego Technologies AB). This update addresses details initially released on September 2, 2026.
The company specifically corrected information regarding Mangold Fondkommission AB. While the initial press release indicated Mangold Fondkommission AB was one of the sellers of the shares, it has now been clarified that Mangold Fondkommission AB solely brokered the sale.
This adjustment clarifies the role of Mangold Fondkommission AB in the transaction, emphasizing its function as an intermediary rather than a seller. The core details of the share acquisition remain consistent.
Peptonic Medical AB continues its strategic initiatives following this clarification and the DGH International acquisition.